ArticleBMC medical imaging2026
Value of intratumoral and peritumoral radiomics based on DCE-MRI in predicting HER2-low and HER2-zero in breast cancer.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to develop and validate intratumoral and peritumoral radiomic models based on DCE-MRI to predict the human epidermal growth factor receptor 2 (HER2) low and zero states of breast cancer(BCa).
methodsThe clinical data of 168 patients with BCa were retrospectively analysed and divided into a training set and a validation set. The intratumoral and peritumoral radiomic features were extracted from DCE-MRI. Variance analysis, univariate logistic analysis, and least absolute shrinkage and selection operator (LASSO) were used as selection operators for dimension reduction. Feature selection and radiomics model construction were performed using max-relevance and min-redundancy (mRMR) and the least absolute shrinkage and selection operator (LASSO) on the training cohort. Logistic regression (LR) was used as a classifier to construct the intratumoral, peritumoral and intratumoral combined peritumoral radiomic models of DCE-MRI. The optimal model was selected to construct the fusion model combined with the screened clinical independent risk factors, and the model was displayed as a nomogram. The performance of each model was evaluated via the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve.
resultsIn the end, a total of 12 features were retained, and the AUC values of the DCE-MRI intratumoral + peritumoral model in the training set and validation set were 0.845 and 0.836, respectively. Age was identified as an independent risk factor for predicting HER2 status in BCa through Univariate and multivariate analysis in the training set.The AUC values of the final constructed nomogram were 0.862 and 0.844 in the training set and validation set, respectively.
conclusionIntratumoral and peritumoral radiomic methods based on DCE-MRI have good value in the identification of HER2-low and HER-zero BCa. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.